BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 87028)

  • 21. [Research on the HLA system in leprosy].
    Baranov IuN; Loginov VK
    Vestn Dermatol Venerol; 1988; (8):30-4. PubMed ID: 3057760
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types.
    de Vries RR; Mehra NK; Vaidya MC; Gupte MD; Meera Khan P; Van Rood JJ
    Tissue Antigens; 1980 Oct; 16(4):294-304. PubMed ID: 7008255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The genetic susceptibility to leprosy in humans].
    Lagrange PH; Abel L
    Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HLA and leprosy in Dakar: distribution of histocompatibility antigens in leprous patients and their relationship to ENL reactions].
    Blavy G; Thiam D; Ndoye B; Diakhate L; Millan J
    Acta Leprol; 1986; 4(1):93-9. PubMed ID: 3526798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigens in forms of leprosy among Japanese patients.
    Joko S; Numaga J; Kawashima H; Namisato M; Maeda H
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):49-56. PubMed ID: 10834069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-A, B and C antigens in South Indian families with leprosy.
    Wolf E; Fine PE; Pritchard J; Watson B; Bradley DJ; Festenstein H; Chacko CJ; Stevens A
    Tissue Antigens; 1980 May; 15(5):436-46. PubMed ID: 7444931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA and sporadic tuberculoid leprosy: a population study in Maharashtra, India.
    van Eden W; Mehra NK; Vaidya MC; D'Amaro J; Schreuder GM; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):189-94. PubMed ID: 7336423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukocyte antigen class I and class II alleles are associated with susceptibility and resistance in borderline leprosy patients from Southeast Brazil.
    de Souza-Santana FC; Marcos EV; Nogueira ME; Ura S; Tomimori J
    BMC Infect Dis; 2015 Jan; 15():22. PubMed ID: 25605482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA and leprosy: segregation and linkage study.
    Dessoukey MW; el-Shiemy S; Sallam T
    Int J Dermatol; 1996 Apr; 35(4):257-64. PubMed ID: 8786183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes.
    Mira MT; Alcais A; di Pietrantonio T; Thuc NV; Phuong MC; Abel L; Schurr E
    Genes Immun; 2003 Jan; 4(1):67-73. PubMed ID: 12595904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculoid leprosy and HLA in Japanese.
    Miyanaga K; Juji T; Maeda H; Nakajima S; Kobayashi S
    Tissue Antigens; 1981 Nov; 18(5):331-4. PubMed ID: 6953616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA antigens in leprosy patients.
    Bale UM; Mehta MM; Contractor NM; Bhatia HM; Koticha KK
    Tissue Antigens; 1982 Aug; 20(2):141-3. PubMed ID: 6982541
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA segregation study in families of leprosy patients.
    Bale UM; Contractor NM; Bhatia HM
    Indian J Med Res; 1985 Sep; 82():198-201. PubMed ID: 4077159
    [No Abstract]   [Full Text] [Related]  

  • 35. Leprosy and immunity: genetics and immune function in multiple case families.
    Rawlinson WD; Basten A; Britton WJ; Serjeantson SW
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():9-21. PubMed ID: 3286485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of leprosy with HLA-DR2 in a Southern Brazilian population.
    Visentainer JE; Tsuneto LT; Serra MF; Peixoto PR; Petzl-Erler ML
    Braz J Med Biol Res; 1997 Jan; 30(1):51-9. PubMed ID: 9222403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil.
    Lavado-Valenzuela R; José Bravo M; Junqueira-Kipnis AP; Ramos de Souza M; Moreno C; Alonso A; Liberman-Kipnis T; da Silva WD; Caballero A
    Int J Immunogenet; 2011 Jun; 38(3):255-8. PubMed ID: 21599852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA antigens and neural reversal reactions in Ethiopian borderline tuberculoid leprosy patients.
    Ottenhoff TH; Converse PJ; Bjune G; de Vries RR
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):261-6. PubMed ID: 3474306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients.
    Vanderborght PR; Pacheco AG; Moraes ME; Antoni G; Romero M; Verville A; Thai VH; Huong NT; Ba NN; Schurr E; Sarno EN; Moraes MO
    Genes Immun; 2007 Jun; 8(4):320-4. PubMed ID: 17396103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
    Collings LA; Tidman N; Poulter LW
    Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.